SCHEMBL7044596

SCHEMBL7044596

C=C(C(=O)c1ccc(S(N)(=O)=O)c(C(C)=O)c1)c1cc(-c2cc3ccccc3[nH]2)c(OC)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
IMPDH2 P12268 1/20 0.36
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
ALOX15 P16050 2/20 0.33
SMO Q99835 2/20 0.33
PKM P14618 1/20 0.33
BRD4 O60885 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565638 0.87 CA2 (0.47) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL6040509 0.81 KDM4E (0.48) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5559825 0.81 ALDH1A1 (0.42) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5564774 0.80 ALDH1A1 (0.41) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5560582 0.80 ALDH1A1 (0.42) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5560109 0.77 KDM4E (0.40) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5560099 0.77 ALDH1A1 (0.40) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5566299 0.76 KAT6A (0.39) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5565348 0.76 ALDH1A1 (0.39) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL5566222 0.76 KDM4E (0.39) KDM4EMAPTMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004108094-A2 SULFONAMIDE-SUBSTITUTED CHALCONE DERIVATIVES AND THEIR USE TO TREAT DISEASES ATHEROGENICS, INC. (US) 2004-12-16 WO disclosed